Two Phase 3 trials found that retatrutide reduced sleep apnea breathing events in adults with and without type 2 diabetes.
Retatrutide for Sleep Apnea: Fewer Breathing Events in Phase 3
Two Phase 3 trials found that retatrutide reduced sleep apnea breathing events in adults with and without type 2 diabetes.